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Developmental cerebral hemodynamic adaptations to chronic high altitude exposure, such 22 
as in the Sherpa population, are largely unknown. To examine hemodynamic adaptations in the 23 
developing human brain, we assessed common carotid (CCA), internal carotid (ICA) and 24 
vertebral artery (VA) flow and middle cerebral artery (MCA) velocity in 25 (9.6±1.0 y, 129±9 25 
cm, 27±8 kg, 14 girls) Sherpa children (3800m, Nepal) and 25 (9.9±0.7 y, 143±7 cm, 34±6 kg, 14 26 
girls) age-matched sea-level children (344m, Canada) during supine rest. Resting gas exchange, 27 
blood pressure, oxygen saturation and heart rate were assessed. Despite comparable age, height 28 
and weight were lower (both P<0.01) in Sherpa compared to sea-level children. Mean arterial 29 
pressure, heart rate and ventilation were similar, whereas oxygen saturation (95±2 vs. 99±1%, 30 
P<0.01) and end-tidal PCO2 (24±3 vs 36±3 mmHg, P<0.01) were lower in Sherpa children. 31 
Global cerebral blood flow was ∼30% lower in Sherpa compared to sea-level children. This was 32 
reflected in a lower ICA flow (283±108 vs. 333±56 ml/min, P=0.05), VA flow (78±26 vs 118±35 33 
ml/min, P<0.05) and MCA velocity (72±14 vs 88±14 cm/s, P<0.01). CCA flow was similar 34 
between Sherpa and sea-level children (425±92 vs. 441±81 ml/min, P=0.52). Scaling flow and 35 
oxygen uptake for differences in vessel diameter and body size respectively, led to the same 36 
findings. A lower cerebral blood flow in Sherpa children may reflect specific cerebral 37 
hemodynamic adaptations to chronic hypoxia.   38 
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New & Noteworthy 39 
Cerebral blood flow is lower in Sherpa children compared to children residing at sea-40 
level; this may reflect a cerebral hemodynamic pattern, potentially due to adaptation to a hypoxic 41 
environment.  42 
 43 
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The human brain is a highly demanding organ using 15% of the total cardiac output and ~ 47 
20% of the oxygen taken up by a human at rest (29). Furthermore, because of the limited 48 
substrate storage, an adequate delivery of oxygen and nutrients to the brain is essential (11). 49 
Limited oxygen availability, as experienced during hypoxia, challenges brain blood flow 50 
regulation to meet its high energy requirements (4, 6). Some animals have evolved to tolerate 51 
extreme limitations of oxygen by lowering energy expenditure and utilization in the brain to 52 
allow survival despite prolonged hypoxemia or anoxia (16). Tibetans and Sherpas who have 53 
migrated from the Tibetan plateau, have adapted to their low-oxygen environment [reviewed: 54 
(14)]. Although other native populations to high altitude exist (e.g., Andeans and Ethiopians), the 55 
Tibetan population have resided at altitudes between 3500 – 4500 m above sea level for the 56 
longest [∼25000 years, (8)] and thus serve as a unique model to study long-term adaptation to 57 
hypobaric hypoxia.  58 
Acute exposure to hypoxia in sea-level residents (Lowlanders) results in an elevation in 59 
cerebral blood flow (CBF) which serves to offset reductions in arterial oxygen content and thus 60 
maintain cerebral oxygen delivery. Over time at a given altitude, when oxygen content improves, 61 
CBF returns towards baseline [reviewed in: (5, 21)]. In Tibetans (and Sherpas) CBF has been 62 
reported to be the same (26) or lower (30) compared to populations residing at sea-level. Existing 63 
data are sparse and mostly based on adults. Exposure to limited oxygen availability during 64 
development can result in reduced birth weight and cardio-pulmonary pathologies, but also 65 
negatively affect neurodevelopment (38). Developmental cerebral hemodynamic adaptations to 66 
chronic high altitude exposure are, however, largely unknown.  67 
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A previous study exposing children (n=9; 9±2 y, 5 boys) normally residing at sea-level to 68 
acute (24 h at 3500 m after a 5 day trek) hypobaric hypoxia (e.g., altitude) resulted in a 29% 69 
increase in the middle cerebral artery (MCA) velocity (13). Evidence from Andean children 70 
demonstrates MCA velocity in those living at 500 m (n=18, 8±2 y, 8 boys) compared to those 71 
living at 3700 m (n=19, 8±1 y, 10 boys) was not different (19). In contrast, the authors reported 72 
that velocity in the basilar artery was lower in those living at high altitude (19). Both studies in 73 
children (13, 19) as well as studies in adults (25, 26) have used transcranial Doppler ultrasound to 74 
assess velocity in the intracranial arteries (MCA or basilar artery). A limitation of this approach is 75 
the assumption that vessel diameter is unchanged, however, hypoxia can lead to changes 76 
(dilation) in the diameter of cerebral arteries (53); which would result in an underestimation of 77 
CBF (1, 20).  78 
  Accordingly, the primary aim of the present study was to compare regional and global 79 
CBF in high altitude Sherpa children and age-matched children residing at sea-level. This aim 80 
was achieved by assessing volumetric flow in the common (CCA) and internal carotid (ICA) 81 
arteries and the vertebral artery (VA) and employing a novel edge detection software approach 82 
(43). We hypothesized that both regional and global CBF would be lower in the Sherpa children 83 
compared to age-matched children residing at sea level.  84 
 85 
Materials and Methods 86 
Ethical Approval 87 
All experimental protocols and procedures were approved by the clinical research ethics 88 
board at the University of British Columbia and the Nepal Health Medical Research Council and 89 
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conformed to the Declaration of Helsinki. This independent project was part of the UBC 90 
expedition to Nepal 2016 which included a larger series of experiments. Prior to participation a 91 
detailed verbal and written explanation of the measurements was provided and each participant 92 
and their parent/guardian completed written informed consent. All documents were provided in 93 
the first language of the participant. The research team consisted of a Nepali and a Sherpa 94 
language translator (SN) to facilitate on-site communication with the high altitude participants. 95 
Participants 96 
Twenty-five Sherpa children (9.6±1.0 y, 14 girls, Thame and Khunde, Nepal, 3800 m) 97 
and 25 age-matched children residing at sea level (9.9±0.7 y, 14 girls, Kelowna, Canada, 340 m) 98 
took part in the study. As determined by an oral screening questionnaire of the Sherpa children by 99 
a Nepalese physician (SN) and the child’s parent/guardian, and a written screening questionnaire 100 
in the children from sea-level completed by their parent/guardian, none of the children were 101 
reported to have any cardiovascular, cerebrovascular or respiratory disease. None of the children 102 
were on prescription or over-the-counter medications. As some of the Sherpa children and their 103 
parents only knew their birthdate in the Nepali calendar, our Nepalese physician (SN) and Sherpa 104 
guide converted these to the Gregorian calendar in order to calculate the specific birthdate. 105 
Experimental measures 106 
Body mass was measured with electronic scales with subjects barefoot and dressed in 107 
light clothing. Stature and sitting height were measured barefoot with a Harpenden stadiometer. 108 
Body mass index (BMI) was calculated from body mass (kg) divided by stature (m2). Predicted 109 
age at peak height velocity (aPHV) was estimated (35) and used to classify the children as pre-110 
adolescent or adolescent. Heart rate (HR) was assessed using a 3-lead electrocardiogram (ECG; 111 
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ADI BioAmp ML132), and blood pressure using an automated cuff (Tango+; SunTech, 112 
Morrisville, NC). Oxygen saturation (SpO2) was measured using a pulse oximeter (Rad-5®, 113 
Masimo SET, Irvine CA, USA) with child-size adhesive sensors (LNCS® Neo, Masimo SET, 114 
Irvine CA, USA). Pulmonary gas exchange [oxygen uptake (VO2), CO2 production (VCO2), 115 
partial pressure of end-tidal CO2 (PetCO2) and O2 (PetO2)], tidal volume (VT), ventilation (VE) 116 
and breathing frequency (BF) were recorded breath by breath using a metabolic cart (Oxycon 117 
Pro, Carefusion, USA), interpolated to 1-s intervals. Children were breathing through a 118 
mouthpiece with their nose occluded using a nose clip. The gas analyzer was calibrated daily 119 
using gases of known concentrations before the first test, and volume was calibrated before each 120 
test in Kelowna and in Nepal. Alveolar ventilation (VA) was estimated according the following 121 
equation: PaCO2 = VCO2 · K / VA, where PaCO2 is the arterial partial pressure of CO2 and K is 122 
0.863 (49). An estimation of PaCO2 was derived from PetCO2 (33). In one child residing at sea-123 
level respiratory data is missing, as such all respiratory data in children residing at sea-level are 124 
based on n=24. Transcranial Doppler Ultrasound (2MHz, TCD, Spencer Technologies, Seattle, 125 
WA) was used to assess middle cerebral artery mean velocity (MCAvmean). To secure the probe in 126 
place the TCD probes were attached to a headpiece (child-sized adjusted model M600 bilateral 127 
head frame, Spencer Technologies). The MCA was insonated through the middle trans-temporal 128 
window, using previously described locations and standardization techniques (50). Due to 129 
insufficient imaging quality in one of the children residing at sea-level, MCAvmean data is based 130 
on n=24 in the sea-level group. Blood velocity and vessel diameter of the left CCA, left ICA and 131 
left VA were measured using a 10 MHz multi-frequency linear array vascular ultrasound 132 
(Terason T3200, Teratech, Burlington, MA). B-mode imaging was used to measure arterial 133 
diameter, while pulse-wave mode was used to simultaneously measure peak blood velocity. 134 
Extracranial blood flow measurements were made in accordance with recent technical 135 
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recommendations (43). All CCA, ICA and VA recordings were screen captured and stored as 136 
video files for offline analysis (55). A minimum of 20 consecutive cardiac cycles were used to 137 
determine extracranial blood flow measurements. Due to insufficient imaging quality in one of 138 
the children residing at sea-level, VA data is based on n=24 in the sea-level group. Volumetric 139 
blood flow was calculated using the following formula:  140 
CCA, ICA or VA flow = CCA, ICA  or VA Peak Envelope Velocity 2 ∙ [ߨ (0.5 ∙ Diameter)
ଶ] 
 Global cerebral blood flow (gCBF) was calculated using the following formula: 141 
gCBF = 2 ( ICA flow + VA flow) 
ECG and MCAvmean were sampled continuously at 1000 Hz using an analogue-to-digital 142 
converter (Powerlab, 16/30; ADInstruments, Colorado Springs, CO, USA) and data were 143 
interfaced with LabChart (Version 7), and analyzed offline.  144 
Study protocol 145 
Sherpa children were either tested in Thame (3800 m, Thame Community Health Clinic, 146 
Thame, Nepal) or in Khunde (3840 m, Khunde Hospital, Khunde, Nepal). Children from sea-147 
level were tested in Kelowna (344 m, Kelowna, Canada). Before any measurements were taken, 148 
children were rested in a supine position for at least 10 min. Thereafter, measurements were taken 149 
supine over a 15 min period while volumetric flow measurements of the CCA, ICA and VA were 150 
assessed consecutively.  151 
Data and statistical analysis 152 
Values were taken as an average over at least 1 minute. Using a two-way ANOVA all 153 
outcome measures were tested for a sex effect; however, since the results revealed an absence of 154 
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difference between girls and boys, data were therefore pooled together. Comparison of the main 155 
outcome variables between Sherpa children and children residing at sea-level were made using a 156 
Student’s t-test. Data are given as mean±SD unless otherwise indicated. To adjust for size 157 
differences in respiratory parameters (adjusted for body mass) and blood flow (vessel size) 158 
between Sherpa children and children from sea-level we applied allometric scaling using a log 159 
linear ANCOVA. Covariate adjusted means (±SE) were obtained from this model. To confirm 160 
whether the allometric adjustment using body mass adequately accounted for differences in size 161 
between the two groups of children, a subset analysis of 8 Sherpa children and 8 size-matched 162 
children residing at sea-level was conducted. Statistical significance was set at P < 0.05. 163 
Statistical analyses were performed using SAS Enterprise Guide (4.3, SAS Institute, Cary, NC). 164 
 165 
Results 166 
 Sherpa children were smaller (129±9 vs. 143±7 cm, P<0.01) and weighed less (27±8 vs. 167 
34±6 kg, P <0.01) compared to the age-matched children residing at sea-level.  Both groups, 168 
however, had a similar BMI (16±2 vs 17±2 kg/m2, P=0.13). Calculation of predicted aPHV 169 
showed both groups were preadolescent; however, Sherpa children show a younger biological 170 
age despite similar chronological age in comparison to children residing at sea-level, with aPHV -171 
3±1 y in Sherpa children vs -2±1 y in children residing at sea-level (P=0.01). Table 1 reports the 172 
cardiovascular and respiratory parameters of Sherpa children and children residing at sea-level. 173 
Briefly, there was no difference in mean arterial pressure (MAP), HR, VE, VA and VT. In contrast, 174 
SpO2, PETCO2, PETO2, VO2 and VCO2 were lower in the Sherpa children, whereas BF was higher 175 
in Sherpa children compared to children residing at sea-level. Scaling VO2 (242±1 vs. 325±1 176 
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ml·l-1, P<0.01), VCO2 (186±1 vs. 250±1 ml·l-1, P<0.01) and VE (8.1±1 vs. 8.6±1 l·min-1, P=0.34) 177 
for body mass did not diminish the difference between Sherpa children and children residing at 178 
sea-level.  179 
Cerebrovascular variables:  Sherpa children had a lower MCAvmean (71.5±13.6 vs. 87.5±14.3 180 
cm·s-1, P<0.01) compared to children residing at sea-level. Figure 1 illustrates the mean velocity, 181 
diameter and mean flow in the CCA, ICA and VA. There was no difference in mean flow in the 182 
CCA between the two groups. In contrast, ICA and VA flow were lower in the Sherpa children 183 
compared to children residing at sea-level. As such, gCBF in Sherpa children was ~ 30% lower 184 
compared to children residing at sea level (Figure 2). Furthermore, VA flow contributed less to 185 
the gCBF in Sherpa children compared to children residing at sea level (22±7% vs. 26±6%, 186 
P=0.03, Figure 2). Adjusting CCA (432±1 vs. 411±1 ml·min-1, p=0.33, mean±SE), ICA (270±1 187 
vs. 317±1 ml·min-1, P<0.01, mean±SE) and VA (82±1 vs. 97±1 ml·min-1, P<0.01, mean±SE) 188 
flow for differences in diameter size between Sherpa children and children residing at sea-level 189 
did not affect the above-mentioned findings. Furthermore, these findings (gCBF, CCA flow, ICA 190 
flow, VA flow and MCAvmean) in Sherpa children versus children residing at sea level persisted 191 
when expressed as cerebrovascular conductance (8.4±1.7 vs. 11.5±2.5 ml·min-1·mmHg-1, 192 
P<0.01; 5.1±1.1 vs. 5.6±1.2 ml·min-1·mmHg-1, P=0.14; 3.3±0.7 vs. 4.3±1.0 ml·min-1·mmHg-1, 193 
P<0.01; 0.9±0.3 vs. 1.5±0.4 ml·min-1·mmHg-1 , P<0.01 and  0.9±0.2 vs. 1.1±0.3 cm·s-1·mmHg-1, 194 
P<0.01, respectively). 195 
Size-matched comparisons: The size-matched comparison resulted in no difference between the 8 196 
Sherpa children and children residing at sea-level in weight and stature (Table 2). Predicted 197 
aPHV showed the same biological age for Sherpa children and the children residing at sea-level 198 
(-2.4±1.3 vs. -2.6±1.0, P=0.83). Similar to the age-matched comparison, Sherpa children showed 199 
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a lower ICA flow, VA flow, gCBF and MCAvmean (P<0.01, Table 2) compared to the children 200 
residing at sea-level. 201 
 202 
Discussion 203 
In this study, for the first time, we assessed global and regional CBF in pre-adolescent Sherpa 204 
children and compared them to age-matched children residing at sea-level. Our main finding was 205 
a 30 % lower gCBF in Sherpa children compared to children residing at sea-level. In contrast, 206 
there was no difference observed in CCA flow, indicating a possible redistribution to the external 207 
circulation. The following discussion considers the evidence, methodological assumptions and 208 
the relevance underlying the findings of this study. 209 
Comparisons with previous studies: Our results are broadly consistent with a recent study 210 
reporting a lower gCBF in Tibetans born and raised at 3200-4500 m compared to Tibetans living 211 
at sea-level for two years (30). The difference in gCBF is somewhat smaller compared to the 212 
present study (~15% vs. ~ 30%) – that may be explained due to (i) the inclusion of data of adults, 213 
(ii) that the comparison was performed between the same ethnicity or (iii) differences in diameter 214 
evident in our dataset. Estimating gCBF using the diameter adjusted ICA and VA mean flows, 215 
attenuates the difference in gCBF between the Sherpa children and sea-level children to ~ 15%. 216 
Similarly, an unpublished dataset comparing adults residing at sea level and adult Sherpas at high 217 
altitude confirms the lower gCBF in the adult Sherpa population (22). Andean children residing 218 
at 3700 m have also been shown to have a reduced basilar artery velocity compared to those 219 
living at sea level (19). A previous study (26), that failed to show a difference in CBF in Sherpa 220 
and Tibetan adults compared to those residing at sea-level, relied on MCAvmean as a measure for 221 
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CBF and thus did not take differences in diameter into account. Assessing only velocity can lead 222 
to an under- or overestimation of flow as in accordance with Poiseuille’s Law, even the smallest 223 
changes in diameter have a major effect on flow [e.g., flow ~ (diameter/2)4]. In a further study 224 
(23) ICA flow was assessed in Tibetans versus Han Chinese adults and no difference was 225 
observed between the two groups; however, the Han Chinese had been living in Lhasa for the last 226 
1-15 years and thus it is not a true comparison between sea-level natives and those native to high 227 
altitude. 228 
Maturation, CBF and hypoxia:  Although the regulation of CBF in adults is relatively well 229 
studied, the influence of maturation is poorly understood in the pediatric brain. Growth and 230 
maturation occur alongside critical surges in neural development, myelination, metabolic 231 
demands and increased cerebral utilization of glucose (3). It is known that global CBF at birth is, 232 
on average, 50 ml (100 g)/ min, increasing after birth to a maximum of 70–80 ml (100 g)/ min at 233 
5–7 years and then decreasing to reach adult levels after 19 years (42). This temporal pattern of 234 
change is probably a consequence of brain development and subsequent ‘shaping’ of neurons, 235 
synapses and pathways that occurs with maturation (3). In our study cohort the Sherpa children 236 
are biologically younger compared to the children residing at sea-level and are smaller, thus 237 
might have a lower brain volume. We also found a smaller arterial diameter in the Sherpa 238 
children compared to those residing at sea-level. It is worth noting that Murray’s law (37) 239 
suggests flow varies with vessel diameter (D3) in arteriolar beds where the relationship between 240 
blood volume and vascular resistance is important for the maintenance and regulation of regional 241 
blood flow. This may provide the most efficient transport of oxygen to the relatively smaller, less 242 
mature and/or high-altitude adapted brain, which may have a relatively lower oxygen uptake 243 
and/or utilization. Nevertheless, the temporal pattern of maturation as well as neurodevelopment 244 
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could, potentially be altered due to exposure to hypoxia (45). Furthermore, cognitive impairments 245 
have been reported in high altitude natives [reviewed in (47, 57)]. Moreover, a recent study has 246 
also shown cognitive impairment in school children residing at high altitude compared to children 247 
going to school at low altitude (48). Whether limited oxygen availability is the only underlying 248 
cause is difficult to define as high altitude natives also face malnutrition, underdeveloped living 249 
infrastructure, as well as poor access to medical care [reviewed in (38, 47)].  250 
Putative mechanism(s) of action: A lower CBF in Sherpa children highlights a cerebral 251 
hemodynamic pattern that may reflect a long term adaptation to chronic hypoxia. A potential 252 
underlying mechanism mediating the lower CBF could be a lower cerebral metabolism as 253 
reported in hypoxia-tolerant animals (16) and Quechua high altitude residents (at sea level) (17). 254 
In Sherpas, cerebral glucose metabolism did not differ in Sherpas, at least when examined at sea 255 
level, in comparison to sea-level residents (18). Data on cerebral metabolism in adult or child 256 
Sherpas at altitude does not exist. We found a markedly lower resting VO2 in the Sherpa children 257 
which was weakly related with gCBF (r2 = 0. 15, p < 0.01). Data on the relationship between VO2 258 
and cerebral metabolism in children is sparse. Evidence in children with traumatic brain injury 259 
shows no relationship between whole body and cerebral metabolism (32), and corroborates our 260 
findings that whole body VO2 plays a minimal role in the variability in gCBF. 261 
At sea-level, changes in arterial PCO2 is well-known to be the major regulator of CBF (27, 51). 262 
Thus, the observed hypocapnia in the Sherpa children at high altitude could be the cause of 263 
vasoconstriction and hence reductions in CBF. We feel this is an unlikely explanation since it is 264 
the extra-cellular pH rather than arterial PCO2 that acts to influence cerebrovascular tone [(28) 265 
and  reviewed in: (52)]. In the context of a sojourn at given altitude, excretion of HCO3 occurs in 266 
order to provide metabolic compensation of the respiratory alkalosis [reviewed in (2)]. Over 2-3 267 
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weeks at 4000m, at least in adults, it is likely that pH would be nearly corrected [reviewed in (2)]; 268 
therefore, this normal hypocapnic / alkalotic stimulus to attenuate CBF is removed (5).  269 
Moreover, as the Sherpa children had a lower biological age and potentially experience lower 270 
growth rate, brain volume might play a role. Brain volume has been shown to increase up to 271 
about 18 years of age. In contrast, gCBF peaks between 4 to 6 years of age, declining thereafter 272 
and as such brain volume and gCBF were not correlated (56). Our findings of a lower gCBF in 273 
the Sherpa children remained when we matched a subgroup by body size, lending support to our 274 
scaling approach.  275 
A further factor affecting blood flow is blood viscosity, as increased blood viscosity can lead to 276 
reduced CBF (15, 24, 25, 34). Exposure to a hypoxic environment stimulates red blood cell 277 
production and thus can result in an increased hematocrit and blood viscosity (40). Hemoglobin 278 
concentrations in high altitude residents were reported to be higher in Andeans than in Tibetans 279 
(and Sherpas), whereas hemoglobin in the latter diverges less from sea-level residents (54). In a 280 
recent study of prepubertal (6-13 years) Tibetan children residing at 4300m (12), hemoglobin 281 
concentrations approximate the 95th percentile for the sea-level US population; these  hemoglobin 282 
concentrations thus do not exceed the normal range seen in this age group at sea level. 283 
Hemoglobin concentration was not acquired in the present data, thus we can only speculate 284 
possible differences in hemoglobin concentrations in the Sherpa children compared to children 285 
residing at sea-level. Furthermore, as an inverse relationship exists between CBF and hemoglobin 286 
to match oxygen content [reviewed in (21)], a higher hemoglobin concentration in Sherpa 287 
children would support the lower CBF compared to children residing at sea-level. Nevertheless, it 288 
seems differences in hemoglobin and blood viscosity between high altitude dwelling Tibetans 289 
15 
 
and sea-level residents are small and likely only contribute to a minor extent to the decreased 290 
gCBF in Sherpa children.  291 
Ventilation and saturation: Interestingly, there was no difference in VE and VA between Sherpa 292 
children and children from sea-level, even when scaled for differences in body mass. Previously, 293 
elevated VE has been shown in Sherpas compared to Andeans and sea-level residents (9). An 294 
increased VE appears to facilitate a higher VO2, compensating for the low oxygen availability 295 
[reviewed in: (8)]. We found rather high SpO2 values when compared to existing data in the same 296 
age group (7, 46). In a more recent study (30) in Tibetan adolescents at 3658 m, the SpO2 values 297 
were similar to those we report a 92%. Furthermore SpO2 peaks at 10-19 years and decreases 298 
during adulthood (7), supporting our higher values in comparison to adult data. Additionally, 299 
higher SpO2 values could be a consequence of a possible left shift of the oxygen dissociation 300 
curve which favors a better pulmonary oxygen uptake in a hypoxic environment (36). This would 301 
support the low PetCO2 values we observed in the Sherpa child and thus potential elevations in 302 
pH (i.e. respiratory alkalosis), promoting a leftward shift in the oxygen dissociation curve.  303 
Regional cerebral blood flow distribution: The left and right CCA and VA supply the head and 304 
brain with blood. The CCA branches into the ICA and the external carotid artery (ECA) at the 305 
carotid bulb and whereas the ICA and VA supply the brain, the ECA supplies the face with 306 
blood. Unlike the ICA and VA, CCA flow was comparable between Sherpa children and children 307 
living at sea-level. Thus, given a similar flow is going to the head in both groups, it would appear 308 
that the lower ICA flow in the Sherpa children would suggest greater flow is distributed towards 309 
the ECA. The distribution towards the ECA could be driven by the “Plateau Red Face” 310 
phenomenon - an expansion of small blood vessels in the face, as observed in high altitude 311 
residents (31). Furthermore, during exercise in the heat, an increase in ECA flow for 312 
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thermoregulation has been observed in adults (39, 41). Whether the likely redistribution of flow 313 
to the ECA in Sherpa children is driven by a small blood vessel expansion or a form of 314 
thermoregulatory adaptation to the high altitude environment remains to be determined. 315 
Likewise, similar to unpublished data on adult Sherpas (22), Sherpa children show a lower 316 
percentage of gCBF distributed to the posterior circulation (Figure 2). Whether the unequal 317 
distribution of ICA, ECA and VA flow in Sherpa children serves as an adaptive mechanism to 318 
long term exposure to high altitude remains speculative. 319 
Methodological considerations: There are a number of methodological considerations that 320 
underlie our findings. The current study contains data from Sherpa children which were collected 321 
in two villages (Thame and Khunde) in Nepal. The sample size and the assessment of CBF for 322 
this study cohort are some of the largest to date. However, field studies, as well as studies in 323 
children, yield limitations such as the lack of blood samples or poor control of pre-testing 324 
guidelines. Additionally, we have attempted to examine two different population groups that are 325 
matched for chronological age; however, stature, mass, maturation and the living environment 326 
diverge between the Sherpa children and children residing at sea-level. Despite allometric scaling 327 
for differences in size, it is impossible to fully overcome this limitation. To partially consider this 328 
influence, in a subset of the study cohort, we matched children for size. The subset analyses 329 
which was independent of size differences supported the lower CBF in Sherpa children compared 330 
to children residing at sea-level. Calculating predicted aPHV to estimate the biological age in the 331 
Sherpa children yields an additional limitation as a slower growth rate has been reported for this 332 
population (44). Thus our biological age calculation most likely has overestimated the biological 333 
age of the Sherpa children. A further consideration is that both groups of children were tested at 334 
the altitude where they were born and raised. For future studies, comparing these children at the 335 
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same altitude, via acclimatizing sea-level residents to high altitude, or by deacclimatizing high 336 
altitude residents to sea-level, would lead to further insight to long term adaptation to a hypoxic 337 
environment in children. 338 
Clinical implications: In many childhood diseases there is a lack of oxygen either due to limited 339 
oxygen uptake, transport or utilization. Thus knowledge describing how children adapt to an 340 
environment where oxygen availability is limited may help to establish optimal mechanisms that 341 
can be incorporated into the development of improved treatments and therapies to help these 342 
children [reviewed in (10)]. Furthermore, there is increasing evidence for children living at high 343 
altitude experiencing cognitive impairment (48). Oxygen conditioning, a technique that enriches 344 
rooms with oxygen (48), could potentially help to improve cognitive abilities in these children. 345 
Whether or not daily oxygen enrichment might enhance cognitive function via a CBF or direct 346 
central nervous system mechanism is unclear. 347 
In conclusion, Sherpa children have a reduced gCBF in comparison to sex and age-348 
matched children from sea-level. A lower CBF in Sherpa children highlights a cerebral 349 
hemodynamic pattern that may reflect a long term adaptation to chronic exposure to a hypoxic 350 
environment.  351 
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Table 1. Cardiovascular and respiratory parameters of age-matched Sherpa children and children 361 
residing at sea-level. 362 
 Sherpa children Sea-level children   P - value 
 n = 25  n = 25   
MAP (mmHg) 82±10 80±11 0.487 
HR (bpm) 87±15 81±9 0.095 
SpO2 (%) 94.6±1.8 99.6±0.7 <0.001 
VE (l min-1) 8.38±1.66 8.67±2.04 0.594 
VA (l min-1) 6.66±1.75 6.53±1.52  0.782 
BF (min-1) 23.3±6.1 20.3±3.6 0.047 
VT (ml) 381.3±109.8 434.4±113.5  0.103 
PETO2 (mmHg) 99.9±6.2 61.3±3.7  <0.001 
PETCO2 (mmHg) 23.6±2.6 36.0±2.7 <0.001 
VO2 (ml) 233.7±42.8 349.5±65.6 <0.001 
VCO2 (ml) 178.0±36.1 275.1±65.0 <0.001 
RER 0.77±0.06 0.76±0.07  0.709 
     
Values are mean±SD. MAP, mean arterial pressure; HR, heart rate; SpO2, oxygen saturation; 363 
VE, ventilation; VA, alveolar ventilation BF, breathing frequency; VT, tidal volume; PetCO2, 364 
end-tidal partial pressure of carbon dioxide; VO2, oxygen uptake; VCO2, carbon dioxide 365 
production; RER, respiratory exchange ratio. P - values represent student’s t-test results. 366 
 367 
 368 
  369 
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Table 2. Cardiovascular, respiratory and cerebrovascular parameters of size-matched Sherpa 370 
children and children residing at sea-level. 371 
 Sherpa children Sea-level children   P - value 
 n = 8  n = 8   
Age (y) 10.2±1.2 9.9±0.7 0.444 
Weight (kg) 32.3±10.8 31.1±6.5 0.793 
Height (cm) 137.7±8.6 138.2±67.6 0.904 
Sitting height (cm) 70.7±4.3 71.3±3.8 0.753 
BMI (kg m-2) 16.7±3.9 16.1±2.0 0.701 
MAP (mmHg) 83±6 81±9  0.535 
HR (bpm) 85±11 82±11  0.482 
SpO2 (%) 93.8±1.0 99.6±0.5 <0.001 
VE (l min-1) 8.18±1.87 7.98±1.58 0.814 
VA (l min-1) 6.02±1.48 6.52±1.70  0.542 
BF (min-1) 21.2±5.0 19.1±3.2 0.339 
PetCO2 (mmHg) 25.1±2.1 35.2±3.2 <0.001 
VO2 (ml) 241.9±43.9 312.2±56.6 0.016 
VCO2 (ml) 187.1±41.7 242.5±45.9 0.024 
RER 0.78±0.06 0.77±0.07  0.838 
CCA velocity (cm s-1) 51.5±5.3 50.0±6.2 0.594 
CCA diameter (cm) 0.58±0.03 0.61±0.05 0.139 
CCA flow (ml min-1) 417.3±47.1 447.5±80.8 0.297 
ICA velocity (cm s-1) 49.2±9.2 60.4±8.0 0.021 
ICA diameter (cm) 0.46±0.03 0.49±0.05 0.257 
ICA flow (ml min-1) 251.3±51.7 338.5±37.5 0.002 
VA velocity (cm s-1) 23.5±1.4 33.4±4.7 <0.001 
VA diameter (cm) 0.35±0.03 0.37±0.03 0.174 
VA flow (ml min-1) 67.3±10.0 107.0±6.2 <0.001 
MCA velocity (cm s-1) 65.3±11.6 93.9±10.7 <0.001 
gCBF (ml min-1) 637.2±93.1 895.7±70.5 0.003 
     
Values are mean±SD. BMI, body mass index; MAP, mean arterial pressure; HR, heart rate; 372 
SpO2, oxygen saturation; VE, ventilation; VA, alveolar ventilation; BF, breathing frequency; VT, 373 
tidal volume; PetCO2, end-tidal partial pressure of carbon dioxide; VO2, oxygen uptake; VCO2, 374 
carbon dioxide production; RER, respiratory exchange ratio; CCA, common carotid artery; 375 
ICA, internal carotid artery; VA, vertebral artery; MCA, middle cerebral artery; gCBF, global 376 






1. Ainslie PN, and Hoiland RL. Transcranial Doppler ultrasound: valid, invalid, or both? J 381 
Appl Physiol (1985) 117: 1081-1083, 2014. 382 
2. Ainslie PN, Lucas SJ, and Burgess KR. Breathing and sleep at high altitude. Respir 383 
Physiol Neurobiol 188: 233-256, 2013. 384 
3. Ainslie PN, and McManus AM. Big brain, small body: towards a better understanding of 385 
cerebrovascular physiology in children. J Physiol 594: 2563, 2016. 386 
4. Ainslie PN, and Ogoh S. Regulation of cerebral blood flow in mammals during chronic 387 
hypoxia: a matter of balance. Exp Physiol 95: 251-262, 2010. 388 
5. Ainslie PN, and Subudhi AW. Cerebral blood flow at high altitude. High Alt Med Biol 15: 389 
133-140, 2014. 390 
6. Ainslie PN, Wilson MH, and Imray CH. The cerebral circulation and brain. In: High 391 
altitude: Human adaptation to hypoxia, edited by Swenson E.R. BP. New York, USA: 392 
Springer, 2014, p. 141-170. 393 
7. Beall CM. Oxygen saturation increases during childhood and decreases during adulthood 394 
among high altitude native Tibetians residing at 3,800-4,200m. High Alt Med Biol 1: 25-32, 395 
2000. 396 
8. Beall CM. Two routes to functional adaptation: Tibetan and Andean high-altitude natives. 397 
Proc Natl Acad Sci U S A 104 Suppl 1: 8655-8660, 2007. 398 
9. Beall CM, Strohl KP, Blangero J, Williams-Blangero S, Almasy LA, Decker MJ, 399 
Worthman CM, Goldstein MC, Vargas E, Villena M, Soria R, Alarcon AM, and 400 
Gonzales C. Ventilation and hypoxic ventilatory response of Tibetan and Aymara high 401 
altitude natives. Am J Phys Anthropol 104: 427-447, 1997. 402 
10. Berger MM, and Grocott MP. Facing acute hypoxia: from the mountains to critical care 403 
medicine. Br J Anaesth 118: 283-286, 2017. 404 
11. Brown AM, and Ransom BR. Astrocyte glycogen and brain energy metabolism. Glia 55: 405 
1263-1271, 2007. 406 
12. Garruto RM, Chin CT, Weitz CA, Liu JC, Liu RL, and He X. Hematological 407 
differences during growth among Tibetans and Han Chinese born and raised at high altitude 408 
in Qinghai, China. Am J Phys Anthropol 122: 171-183, 2003. 409 
13. Gavlak JC, Stocks J, Laverty A, Fettes E, Bucks R, Sonnappa S, Cooper J, Grocott 410 
MP, Levett DZ, Martin DS, Imray CH, and Kirkham FJ. The Young Everest Study: 411 
preliminary report of changes in sleep and cerebral blood flow velocity during slow ascent 412 
to altitude in unacclimatised children. Arch Dis Child 98: 356-362, 2013. 413 
22 
 
14. Gilbert-Kawai ET, Milledge JS, Grocott MP, and Martin DS. King of the mountains: 414 
Tibetan and Sherpa physiological adaptations for life at high altitude. Physiology 415 
(Bethesda) 29: 388-402, 2014. 416 
15. Grotta J, Ackerman R, Correia J, Fallick G, and Chang J. Whole blood viscosity 417 
parameters and cerebral blood flow. Stroke 13: 296-301, 1982. 418 
16. Hochachka PW. Defense strategies against hypoxia and hypothermia. Science 231: 234-419 
241, 1986. 420 
17. Hochachka PW, Clark CM, Brown WD, Stanley C, Stone CK, Nickles RJ, Zhu GG, 421 
Allen PS, and Holden JE. The brain at high altitude: hypometabolism as a defense against 422 
chronic hypoxia? J Cereb Blood Flow Metab 14: 671-679, 1994. 423 
18. Hochachka PW, Clark CM, Monge C, Stanley C, Brown WD, Stone CK, Nickles RJ, 424 
and Holden JE. Sherpa brain glucose metabolism and defense adaptations against chronic 425 
hypoxia. J Appl Physiol (1985) 81: 1355-1361, 1996. 426 
19. Hogan AM, Virues-Ortega J, Botti AB, Bucks R, Holloway JW, Rose-Zerilli MJ, 427 
Palmer LJ, Webster RJ, Baldeweg T, and Kirkham FJ. Development of aptitude at 428 
altitude. Dev Sci 13: 533-544, 2010. 429 
20. Hoiland RL, and Ainslie PN. CrossTalk proposal: The middle cerebral artery diameter 430 
does change during alterations in arterial blood gases and blood pressure. J Physiol 2016. 431 
21. Hoiland RL, Bain AR, Rieger MG, Bailey DM, and Ainslie PN. Hypoxemia, oxygen 432 
content, and the regulation of cerebral blood flow. Am J Physiol Regul Integr Comp Physiol 433 
310: R398-413, 2016. 434 
22. Hoiland RL, Howe CA, Carter HH, Tremblay JC, Willie CK, Donelly J, Stembridge 435 
M, and Ainslie PN. Reduced cerebral blood flow and oxygen delivery in Sherpa compared 436 
to low-landers upon ascent to high-altitude: UBC Nepal Expedition 2016. Hypoxia 437 
Symposium 2017 Abstract 2017. 438 
23. Huang SY, Sun S, Droma T, Zhuang J, Tao JX, McCullough RG, McCullough RE, 439 
Micco AJ, Reeves JT, and Moore LG. Internal carotid arterial flow velocity during 440 
exercise in Tibetan and Han residents of Lhasa (3,658 m). J Appl Physiol (1985) 73: 2638-441 
2642, 1992. 442 
24. Humphrey PR, Michael J, and Pearson TC. Management of relative polycythaemia: 443 
studies of cerebral blood flow and viscosity. Br J Haematol 46: 427-433, 1980. 444 
25. Jansen GF, and Basnyat B. Brain blood flow in Andean and Himalayan high-altitude 445 
populations: evidence of different traits for the same environmental constraint. J Cereb 446 
Blood Flow Metab 31: 706-714, 2011. 447 
26. Jansen GF, Krins A, Basnyat B, Bosch A, and Odoom JA. Cerebral autoregulation in 448 
subjects adapted and not adapted to high altitude. Stroke 31: 2314-2318, 2000. 449 
23 
 
27. Kety SS, and Schmidt CF. The Effects of Altered Arterial Tensions of Carbon Dioxide 450 
and Oxygen on Cerebral Blood Flow and Cerebral Oxygen Consumption of Normal Young 451 
Men. J Clin Invest 27: 484-492, 1948. 452 
28. Kontos HA, Wei EP, Raper AJ, and Patterson JL, Jr. Local mechanism of CO2 action 453 
of cat pial arterioles. Stroke 8: 226-229, 1977. 454 
29. Lassen NA. Cerebral blood flow and oxygen consumption in man. Physiol Rev 39: 183-455 
238, 1959. 456 
30. Liu J, Liu Y, Ren LH, Li L, Wang Z, Liu SS, Li SZ, and Cao TS. Effects of race and 457 
sex on cerebral hemodynamics, oxygen delivery and blood flow distribution in response to 458 
high altitude. Sci Rep 6: 30500, 2016. 459 
31. Ma L, Chen Y, Jin G, Yang Y, Ga Q, and Ge RL. Vascular Endothelial Growth Factor 460 
as a Prognostic Parameter in Subjects with "Plateau Red Face". High Alt Med Biol 16: 147-461 
153, 2015. 462 
32. Matthews DS, Matthews JN, Aynsley-Green A, Bullock RE, and Eyre JA. Changes in 463 
cerebral oxygen consumption are independent of changes in body oxygen consumption 464 
after severe head injury in childhood. J Neurol Neurosurg Psychiatry 59: 359-367, 1995. 465 
33. McSwain SD, Hamel DS, Smith PB, Gentile MA, Srinivasan S, Meliones JN, and 466 
Cheifetz IM. End-tidal and arterial carbon dioxide measurements correlate across all levels 467 
of physiologic dead space. Respir Care 55: 288-293, 2010. 468 
34. Milledge JS, and Sorensen SC. Cerebral arteriovenous oxygen difference in man native to 469 
high altitude. J Appl Physiol 32: 687-689, 1972. 470 
35. Mirwald RL, Baxter-Jones AD, Bailey DA, and Beunen GP. An assessment of maturity 471 
from anthropometric measurements. Med Sci Sports Exerc 34: 689-694, 2002. 472 
36. Morpurgo G, Arese P, Bosia A, Pescarmona GP, Luzzana M, Modiano G, and 473 
Krishna ranjit S. Sherpas living permanently at high altitutde: a new pattern of adaptation. 474 
Proc Natl Acad Sci U S A 73: 747-751, 1976. 475 
37. Murray CD. The Physiological Principle of Minimum Work: I. The Vascular System and 476 
the Cost of Blood Volume. Proc Natl Acad Sci U S A 12: 207-214, 1926. 477 
38. Niermeyer S, Andrade Mollinedo P, and Huicho L. Child health and living at high 478 
altitude. Arch Dis Child 94: 806-811, 2009. 479 
39. Ogoh S, Sato K, Okazaki K, Miyamoto T, Hirasawa A, and Shibasaki M. 480 
Hyperthermia modulates regional differences in cerebral blood flow to changes in CO2. J 481 
Appl Physiol (1985) 117: 46-52, 2014. 482 
24 
 
40. Rasmussen P, Siebenmann C, Diaz V, and Lundby C. Red cell volume expansion at 483 
altitude: a meta-analysis and Monte Carlo simulation. Med Sci Sports Exerc 45: 1767-1772, 484 
2013. 485 
41. Sato K, Oue A, Yoneya M, Sadamoto T, and Ogoh S. Heat stress redistributes blood 486 
flow in arteries of the brain during dynamic exercise. J Appl Physiol (1985) 120: 766-773, 487 
2016. 488 
42. Takahashi T, Shirane R, Sato S, and Yoshimoto T. Developmental changes of cerebral 489 
blood flow and oxygen metabolism in children. AJNR Am J Neuroradiol 20: 917-922, 490 
1999. 491 
43. Thomas KN, Lewis NC, Hill BG, and Ainslie PN. Technical recommendations for the 492 
use of carotid duplex ultrasound for the assessment of extracranial blood flow. Am J 493 
Physiol Regul Integr Comp Physiol 309: R707-720, 2015. 494 
44. Tripathy V, and Gupta R. Growth among Tibetans at high and low altitudes in India. Am 495 
J Hum Biol 19: 789-800, 2007. 496 
45. Wehby GL. Living on higher ground reduces child neurodevelopment-evidence from 497 
South America. J Pediatr 162: 606-611 e601, 2013. 498 
46. Weitz CA, and Garruto RM. A comparative analysis of arterial oxygen saturation among 499 
Tibetans and Han born and raised at high altitude. High Alt Med Biol 8: 13-26, 2007. 500 
47. West JB. Are Permanent Residents of High Altitude Fully Adapted to Their Hypoxic 501 
Environment? High Alt Med Biol 2017. 502 
48. West JB. Cognitive Impairment of School Children at High Altitude: The Case for Oxygen 503 
Conditioning in Schools. High Alt Med Biol 17: 203-207, 2016. 504 
49. West JB. Respiratory Physiology: The Essentials. Baltimore: Lippincott Williams and 505 
Wilkins, 2000. 506 
50. Willie CK, Colino FL, Bailey DM, Tzeng YC, Binsted G, Jones LW, Haykowsky MJ, 507 
Bellapart J, Ogoh S, Smith KJ, Smirl JD, Day TA, Lucas SJ, Eller LK, and Ainslie 508 
PN. Utility of transcranial Doppler ultrasound for the integrative assessment of 509 
cerebrovascular function. J Neurosci Methods 196: 221-237, 2011. 510 
51. Willie CK, Macleod DB, Shaw AD, Smith KJ, Tzeng YC, Eves ND, Ikeda K, Graham 511 
J, Lewis NC, Day TA, and Ainslie PN. Regional brain blood flow in man during acute 512 
changes in arterial blood gases. J Physiol 590: 3261-3275, 2012. 513 
52. Willie CK, Tzeng YC, Fisher JA, and Ainslie PN. Integrative regulation of human brain 514 
blood flow. J Physiol 592: 841-859, 2014. 515 
53. Wilson MH, Edsell ME, Davagnanam I, Hirani SP, Martin DS, Levett DZ, Thornton 516 
JS, Golay X, Strycharczuk L, Newman SP, Montgomery HE, Grocott MP, Imray CH, 517 
25 
 
and Caudwell Xtreme Everest Research G. Cerebral artery dilatation maintains cerebral 518 
oxygenation at extreme altitude and in acute hypoxia--an ultrasound and MRI study. J 519 
Cereb Blood Flow Metab 31: 2019-2029, 2011. 520 
54. Winslow RM, Chapman KW, Gibson CC, Samaja M, Monge CC, Goldwasser E, 521 
Sherpa M, Blume FD, and Santolaya R. Different hematologic responses to hypoxia in 522 
Sherpas and Quechua Indians. J Appl Physiol (1985) 66: 1561-1569, 1989. 523 
55. Woodman RJ, Playford DA, Watts GF, Cheetham C, Reed C, Taylor RR, Puddey IB, 524 
Beilin LJ, Burke V, Mori TA, and Green D. Improved analysis of brachial artery 525 
ultrasound using a novel edge-detection software system. J Appl Physiol (1985) 91: 929-526 
937, 2001. 527 
56. Wu C, Honarmand AR, Schnell S, Kuhn R, Schoeneman SE, Ansari SA, Carr J, 528 
Markl M, and Shaibani A. Age-Related Changes of Normal Cerebral and Cardiac Blood 529 
Flow in Children and Adults Aged 7 Months to 61 Years. J Am Heart Assoc 5: 2016. 530 
57. Yan X. Cognitive impairments at high altitudes and adaptation. High Alt Med Biol 15: 141-531 
145, 2014. 532 
  533 
26 
 
Figure captions 534 
Figure 1 535 
Mean velocity, diameter and mean blood flow of the common carotid, internal carotid and 536 
vertebral artery presented as mean and individual data in Sherpa children (black bars and open 537 
circles) and children from sea-level (open bars and black circles). P - values represent student’s t-538 
test results. * P<0.05 compared to children from sea-level. 539 
 540 
Figure 2 541 
Global cerebral blood flow in Sherpa children (black bars and open circles) and children from 542 
sea-level (open bars and black circles). Grey bars represent percentage of vertebral artery flow. * 543 
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